BDBM674277 3,5-difluoro-4- hydroxy-N-({(1r,4r)- 4-[6-(6-methoxy- pyridin-3-yl)-2H- indazol-2-yl] cyclohexyl}methyl) benzamide, trifluoroacetate salt::US20240150334, Example 108

SMILES COc1ccc(-c2ccc3cn([C@H]4CC[C@H](CNC(=O)c5cc(F)c(O)c(F)c5)CC4)nc3c2)cn1

InChI Key InChIKey=PDAGADQBWJEGSC-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 674277   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Pfizer

US Patent
LigandChemical structure of BindingDB Monomer ID 674277BDBM674277(3,5-difluoro-4- hydroxy-N-({(1r,4r)- 4-[6-(6-metho...)
Affinity DataIC50: 10nMAssay Description:HSD17B13 uses the oxidized form of nicotinamide adenine dinucleotide (NAD+) as a cofactor during metabolism of beta-estradiol (substrate), converting...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2024
Entry Details
US Patent